Skip to main content

Beneficial ownership — 13D / 13G

87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
MANGROVE PARTNERS IM, LLC DSAQ Direct Selling Acquisition Corp. 13G 5.31% 2y
Brian Hirsch KPLT Katapult Holdings, Inc. 13G/A 5.1% 2y
RA CAPITAL MANAGEMENT, L.P. APGE Apogee Therapeutics, Inc. 13G 5.3% 2y
BROWN CAPITAL MANAGEMENT LLC HLIO Helios Technologies, Inc. 13G/A 9.42% 2y
Ian Jacobs SERV Serve Robotics Inc. 13G/A 0.5% 2y
FIR TREE CAPITAL MANAGEMENT LP DHAI DIH Holdings US, Inc. Class A Common Stock 13G/A 5.7% 2y
T. Rowe Price Investment Management, Inc. BLFY Blue Foundry Bancorp 13G/A 11% 2y
T. Rowe Price Investment Management, Inc. RENT Rent the Runway, Inc. 13G 6.3% 2y
T. Rowe Price Investment Management, Inc. PAR Par Technology Corp 13G/A 18.1% 2y
BAKER BROS. ADVISORS LP CABA Cabaletta Bio, Inc. 13G/A 3.4% 2y
ARMISTICE CAPITAL, LLC GOVX GeoVax Labs, Inc. 13G 9.99% 2y
BROWN CAPITAL MANAGEMENT LLC KIDS Orthopediatrics Corp 13G/A 14.21% 2y
Lytton, Laurence W. RNG RingCentral, Inc. 13G/A 1.8% 2y
Sandia Investment Management LP BHAC Focus Impact BH3 Acquisition Company Class A Common Stock 13G/A 1.81% 2y
MOORE CAPITAL MANAGEMENT, LP GCTS GCT Semiconductor Holding, Inc. 13G 7.2% 2y
Venrock Healthcare Capital Partners II, L.P. TRVI Trevi Therapeutics, Inc. 13G/A 9.99% 2y
Andrew J. Schwab SCPH scPharmaceuticals Inc. Common Stock 13G/A 3.3% 2y
Gregory S. Daily IIIV i3 Verticals, Inc. 13G/A 24.4% 2y
GLAZER CAPITAL, LLC IVCA Investcorp AI Acquisition Corp. Class A Ordinary Share 13G/A 13.77% 2y
Redmile Group, LLC IMGN Immunogen Inc 13G/A 5.9% 2y
First Trust Capital Management L.P. OAKU Oak Woods Acquisition Corp 13G 9.36% 2y
AMERIPRISE FINANCIAL INC BE Bloom Energy Corp 13G/A 14.49% 2y
COHEN & STEERS, INC. HIW Highwoods Properties, Inc. 13G/A 16.15% 2y
First Trust Capital Management L.P. RENEF Cartesian Growth Corp II 13G 5.49% 2y
ARMISTICE CAPITAL, LLC COSM Cosmos Health Inc. 13G 9.99% 2y
Cormorant Asset Management, LP OLMA Olema Oncology, Inc. 13G/A 4.49% 2y
ATW SPAC MANAGEMENT LLC ECDA ECD Automotive Design, Inc. 13G/A 0.5% 2y
Paradigm Biocapital Advisors LP AUTL Autolus Therapeutics plc 13G/A 7.2% 2y
ALLIANCEBERNSTEIN L.P. CULL Cullman Bancorp, Inc. 13G 7.4% 2y
PAR Investment Partners, L.P. TRIP TripAdvisor, Inc. 13G/A 3.7% 2y
Cummins Inc. ATMU Atmus Filtration Technologies Inc. 13G 80.5% 2y
Verition Fund Management LLC LRMR Larimar Therapeutics, Inc. 13G 6.4% 2y
LONE PINE CAPITAL LLC RH Rh 13G/A 0% 2y
Magnuson William BRZE Braze, Inc. 13G/A 6.6% 2y
Fort Baker Capital Management LP LOKM Live Oak Mobility Acquisition Corp. 13G/A 0% 2y
Fund 1 Investments, LLC VRA Vera Bradley, Inc. 13G/A 5.72% 2y
Paradigm Biocapital Advisors LP IRON Disc Medicine, Inc. 13G/A 9.9% 2y
FIR TREE CAPITAL MANAGEMENT LP HHLA HH&L Acquisition Co. 13G 9.9% 2y
Sky Top Capital International Limited SFWL SHENGFENG DEVELOPMENT Ltd 13G 7.1% 2y
EdgePoint Investment Group Inc. TCX Tucows Inc 13G/A 19.3% 2y
D. E. Shaw & Co., L.P. TCOA Zalatoris Acquisition Corp. 13G/A 0% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC MPV Barings Participation Investors 13G/A 5.9% 2y
Pamplona Capital Partners V, L.P. SWIM Latham Group, Inc. 13G/A 45.2% 2y
Arthur T. Sands NRIX Nurix Therapeutics, Inc. 13G 5.4% 2y
Soviero Asset Management, LP PBPB Potbelly Corporation Common Stock 13G/A 5.6% 2y
Pentwater Capital Management LP ICVX Icosavax, Inc. Common Stock 13G 5.9% 2y
MAVERICK CAPITAL LTD WVE Wave Life Sciences, Inc. 13G/A 6.9% 2y
Schuurman Steven ESTC Elastic N.V. 13G/A 9.2% 2y
T. Rowe Price Investment Management, Inc. FIGS FIGS, Inc. 13G 5.9% 2y
Harvey Partners, LLC GLDD Great Lakes Dredge & Dock CORP 13G/A 5.1% 2y